State health officials announced their intent to expand the program to include chronic pain patients late last year. The law defines ‘intractable pain’ as a health condition “in which the cause of the pain cannot be removed or otherwise treated with the consent of the patient and in which, in the generally accepted course of medical practice, no relief or cure of the cause of the pain is possible, or none has been found after reasonable efforts.”
As passed in 2014, the law prohibited chronic pain patients from accessing medical cannabis products. The program permits no more than two state-licensed medical manufacturers of cannabis and eight dispensaries, which are only permitted to provide oils, pills, and/or extracts prepared from the plant.
For more information, please contact Paul Armentano, NORML Deputy Director.